Patent Yard Sign in
Canadian application, no grantCanada

Combination chemotherapy comprising gemcitabine and a liposomal platinum complex

CA 2525952 A1 · Owner: Aronex Pharmaceuticals, Inc. · Inventors: Hoos, Axel; Lewis, Jonathan; Gale, Robert Peter

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The present invention relates to methods for treating cancer comprising administering a combination of gemcitabine and a liposomal platinum complex pharmaceutical compositions comprising gemcitabine and a liposomal platinum complex, and kits comprising unit dosage forms of gemcitabine and a liposomal platinum complex.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed May 20, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 20, 2023.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 20, 2025.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMay 20, 2003
GrantedNo grant recorded
Term endedMay 20, 2023
Patent numberCA 2525952 A1
Classification (IPC)A61K9/12 +1 more

Timeline

Timeline From CIPO dates

2004200620082010201220142016201820202022Application filedMay 20, 2003Term endedMay 20, 2023

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.